5-Fluorouracil filtering surgery and neovascular glaucoma: Long-term follow-up of the original pilot study

J. C. Tsai, William J Feuer, Richard K Parrish, Alana Lee Grajewski, R. Ritch

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Background: The long-term efficacy and safety of filtering surgery with S- fluorouracil (5-FU) in eyes with neovascular glaucoma are unknown. Methods: Kaplan-Meier survival curve analysis of surgical outcome was performed on all 34 patients (34 eyes) enrolled from May 1982 through April 1986 in the original pilot study of filtering surgery with 5-FU. Results: Success rates at the 1-, 2-, 3-, 4-, and 5-year intervals were 71%, 67%, 61%, 41%, and 28%, respectively. The median filter survival time was 38.7 months (95% confidence interval: 32-45 months). Twelve (35%) of 34 patients lost light perception vision, and phthisis bulbi developed in 8 (24%) of 34 patients. Age of 50 years or younger (P < 0.0001) and type 1 diabetes (P = 0.0004) were significant risk factors for surgical failure. The 1-year success rate for patients no older than 50 years of age was 23% compared with a 95% success rate in patients older than 50 years of age. After adjustment for age, type 1 diabetes was a borderline risk factor (P = 0.06). Conclusion: There is a high risk of long-term failure of filtering surgery with 5-FU in neovascular glaucoma. Patients 50 years of age or younger have an extremely poor prognosis. Patients older than 50 years of age have initial short-term success with an accelerated failure rate after 3 years.

Original languageEnglish
Pages (from-to)887-893
Number of pages7
JournalOphthalmology
Volume102
Issue number6
StatePublished - Jun 26 1995

Fingerprint

Neovascular Glaucoma
Filtering Surgery
Fluorouracil
Type 1 Diabetes Mellitus
Kaplan-Meier Estimate
Survival Analysis
Confidence Intervals
Safety
Light
Survival

ASJC Scopus subject areas

  • Ophthalmology

Cite this

5-Fluorouracil filtering surgery and neovascular glaucoma : Long-term follow-up of the original pilot study. / Tsai, J. C.; Feuer, William J; Parrish, Richard K; Grajewski, Alana Lee; Ritch, R.

In: Ophthalmology, Vol. 102, No. 6, 26.06.1995, p. 887-893.

Research output: Contribution to journalArticle

@article{b5cb8cdd5380416c97637efa126972a1,
title = "5-Fluorouracil filtering surgery and neovascular glaucoma: Long-term follow-up of the original pilot study",
abstract = "Background: The long-term efficacy and safety of filtering surgery with S- fluorouracil (5-FU) in eyes with neovascular glaucoma are unknown. Methods: Kaplan-Meier survival curve analysis of surgical outcome was performed on all 34 patients (34 eyes) enrolled from May 1982 through April 1986 in the original pilot study of filtering surgery with 5-FU. Results: Success rates at the 1-, 2-, 3-, 4-, and 5-year intervals were 71{\%}, 67{\%}, 61{\%}, 41{\%}, and 28{\%}, respectively. The median filter survival time was 38.7 months (95{\%} confidence interval: 32-45 months). Twelve (35{\%}) of 34 patients lost light perception vision, and phthisis bulbi developed in 8 (24{\%}) of 34 patients. Age of 50 years or younger (P < 0.0001) and type 1 diabetes (P = 0.0004) were significant risk factors for surgical failure. The 1-year success rate for patients no older than 50 years of age was 23{\%} compared with a 95{\%} success rate in patients older than 50 years of age. After adjustment for age, type 1 diabetes was a borderline risk factor (P = 0.06). Conclusion: There is a high risk of long-term failure of filtering surgery with 5-FU in neovascular glaucoma. Patients 50 years of age or younger have an extremely poor prognosis. Patients older than 50 years of age have initial short-term success with an accelerated failure rate after 3 years.",
author = "Tsai, {J. C.} and Feuer, {William J} and Parrish, {Richard K} and Grajewski, {Alana Lee} and R. Ritch",
year = "1995",
month = "6",
day = "26",
language = "English",
volume = "102",
pages = "887--893",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - 5-Fluorouracil filtering surgery and neovascular glaucoma

T2 - Long-term follow-up of the original pilot study

AU - Tsai, J. C.

AU - Feuer, William J

AU - Parrish, Richard K

AU - Grajewski, Alana Lee

AU - Ritch, R.

PY - 1995/6/26

Y1 - 1995/6/26

N2 - Background: The long-term efficacy and safety of filtering surgery with S- fluorouracil (5-FU) in eyes with neovascular glaucoma are unknown. Methods: Kaplan-Meier survival curve analysis of surgical outcome was performed on all 34 patients (34 eyes) enrolled from May 1982 through April 1986 in the original pilot study of filtering surgery with 5-FU. Results: Success rates at the 1-, 2-, 3-, 4-, and 5-year intervals were 71%, 67%, 61%, 41%, and 28%, respectively. The median filter survival time was 38.7 months (95% confidence interval: 32-45 months). Twelve (35%) of 34 patients lost light perception vision, and phthisis bulbi developed in 8 (24%) of 34 patients. Age of 50 years or younger (P < 0.0001) and type 1 diabetes (P = 0.0004) were significant risk factors for surgical failure. The 1-year success rate for patients no older than 50 years of age was 23% compared with a 95% success rate in patients older than 50 years of age. After adjustment for age, type 1 diabetes was a borderline risk factor (P = 0.06). Conclusion: There is a high risk of long-term failure of filtering surgery with 5-FU in neovascular glaucoma. Patients 50 years of age or younger have an extremely poor prognosis. Patients older than 50 years of age have initial short-term success with an accelerated failure rate after 3 years.

AB - Background: The long-term efficacy and safety of filtering surgery with S- fluorouracil (5-FU) in eyes with neovascular glaucoma are unknown. Methods: Kaplan-Meier survival curve analysis of surgical outcome was performed on all 34 patients (34 eyes) enrolled from May 1982 through April 1986 in the original pilot study of filtering surgery with 5-FU. Results: Success rates at the 1-, 2-, 3-, 4-, and 5-year intervals were 71%, 67%, 61%, 41%, and 28%, respectively. The median filter survival time was 38.7 months (95% confidence interval: 32-45 months). Twelve (35%) of 34 patients lost light perception vision, and phthisis bulbi developed in 8 (24%) of 34 patients. Age of 50 years or younger (P < 0.0001) and type 1 diabetes (P = 0.0004) were significant risk factors for surgical failure. The 1-year success rate for patients no older than 50 years of age was 23% compared with a 95% success rate in patients older than 50 years of age. After adjustment for age, type 1 diabetes was a borderline risk factor (P = 0.06). Conclusion: There is a high risk of long-term failure of filtering surgery with 5-FU in neovascular glaucoma. Patients 50 years of age or younger have an extremely poor prognosis. Patients older than 50 years of age have initial short-term success with an accelerated failure rate after 3 years.

UR - http://www.scopus.com/inward/record.url?scp=0029056782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029056782&partnerID=8YFLogxK

M3 - Article

C2 - 7777295

AN - SCOPUS:0029056782

VL - 102

SP - 887

EP - 893

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 6

ER -